Iontophoresis of nafarelin

effects of current density and concentration on electrotransport in vitro

Begona Delgado-Charro, Amalia M. Rodríguez-Bayón, Richard H. Guy

Research output: Contribution to journalArticle

Abstract

The effects of administered concentration and applied current density on the iontophoresis of the leutinizing hormone releasing hormone (LHRH) analog, Nafarelin, have been studied in vitro. Peptide electrotransport, at fixed current density as a function of concentration, and at fixed concentration as a function of current density, has been measured across hairless mouse skin. The results indicate that Nafarelin delivery does not increase linearly with applied concentration: while there is an increase when the donor concentration is doubled from 0.5 to 1.0 mg/ml, further increments in applied peptide level result in decreased transport. At constant concentration, Nafarelin flux does increase with increasing current density (up to 0.63 mA/cm2), but the dependence is very weak. Further experiments utilizing radiolabeled mannitol as a neutral marker of electroosmosis revealed that Nafarelin electrotransport is very sensitive to the extent and direction of convective flow. With increasing amounts of applied Nafarelin, reversal of electroosmosis (from the anode-to-cathode to the cathode-to-anode direction) was apparent; it appeared that the cationic peptide associated strongly with, and neutralized, the net negative charge on the skin, thereby resulting in depression and, ultimately, reversal of the convective flow. This, in turn, inhibits Nafarelin transport by the electroosmotic mechanism and explains, we believe, both the inverse dependence of flux upon concentration and the only weakly dependent behavior upon current density (where, although more current delivers more ions, more current also drives more peptide into the skin and thereby diminishes electroosmosis). Overall, then, this research emphasizes the complicated interplay between peptide structure, skin electrical properties and formulation variables which must be carefully considered in the development and optimization of an iontophoretic drug delivery device.

Original languageEnglish
Pages (from-to)35-40
Number of pages6
JournalJournal of Controlled Release
Volume35
Issue number1
DOIs
Publication statusPublished - Jul 1995

Fingerprint

Nafarelin
Iontophoresis
Electroosmosis
Electrodes
Peptides
Skin
Hormones
Hairless Mouse
Mannitol
In Vitro Techniques
Ions
Depression
Equipment and Supplies

Keywords

  • Electroosmosis
  • Iontophoresis
  • Nafarelin
  • Peptide delivery
  • Skin
  • Transdermal delivery

Cite this

Iontophoresis of nafarelin : effects of current density and concentration on electrotransport in vitro. / Delgado-Charro, Begona; Rodríguez-Bayón, Amalia M.; Guy, Richard H.

In: Journal of Controlled Release, Vol. 35, No. 1, 07.1995, p. 35-40.

Research output: Contribution to journalArticle

@article{0eb95265c2e7429d87eaafe2381d15bb,
title = "Iontophoresis of nafarelin: effects of current density and concentration on electrotransport in vitro",
abstract = "The effects of administered concentration and applied current density on the iontophoresis of the leutinizing hormone releasing hormone (LHRH) analog, Nafarelin, have been studied in vitro. Peptide electrotransport, at fixed current density as a function of concentration, and at fixed concentration as a function of current density, has been measured across hairless mouse skin. The results indicate that Nafarelin delivery does not increase linearly with applied concentration: while there is an increase when the donor concentration is doubled from 0.5 to 1.0 mg/ml, further increments in applied peptide level result in decreased transport. At constant concentration, Nafarelin flux does increase with increasing current density (up to 0.63 mA/cm2), but the dependence is very weak. Further experiments utilizing radiolabeled mannitol as a neutral marker of electroosmosis revealed that Nafarelin electrotransport is very sensitive to the extent and direction of convective flow. With increasing amounts of applied Nafarelin, reversal of electroosmosis (from the anode-to-cathode to the cathode-to-anode direction) was apparent; it appeared that the cationic peptide associated strongly with, and neutralized, the net negative charge on the skin, thereby resulting in depression and, ultimately, reversal of the convective flow. This, in turn, inhibits Nafarelin transport by the electroosmotic mechanism and explains, we believe, both the inverse dependence of flux upon concentration and the only weakly dependent behavior upon current density (where, although more current delivers more ions, more current also drives more peptide into the skin and thereby diminishes electroosmosis). Overall, then, this research emphasizes the complicated interplay between peptide structure, skin electrical properties and formulation variables which must be carefully considered in the development and optimization of an iontophoretic drug delivery device.",
keywords = "Electroosmosis, Iontophoresis, Nafarelin, Peptide delivery, Skin, Transdermal delivery",
author = "Begona Delgado-Charro and Rodr{\'i}guez-Bay{\'o}n, {Amalia M.} and Guy, {Richard H.}",
year = "1995",
month = "7",
doi = "10.1016/0168-3659(95)00015-Z",
language = "English",
volume = "35",
pages = "35--40",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Iontophoresis of nafarelin

T2 - effects of current density and concentration on electrotransport in vitro

AU - Delgado-Charro, Begona

AU - Rodríguez-Bayón, Amalia M.

AU - Guy, Richard H.

PY - 1995/7

Y1 - 1995/7

N2 - The effects of administered concentration and applied current density on the iontophoresis of the leutinizing hormone releasing hormone (LHRH) analog, Nafarelin, have been studied in vitro. Peptide electrotransport, at fixed current density as a function of concentration, and at fixed concentration as a function of current density, has been measured across hairless mouse skin. The results indicate that Nafarelin delivery does not increase linearly with applied concentration: while there is an increase when the donor concentration is doubled from 0.5 to 1.0 mg/ml, further increments in applied peptide level result in decreased transport. At constant concentration, Nafarelin flux does increase with increasing current density (up to 0.63 mA/cm2), but the dependence is very weak. Further experiments utilizing radiolabeled mannitol as a neutral marker of electroosmosis revealed that Nafarelin electrotransport is very sensitive to the extent and direction of convective flow. With increasing amounts of applied Nafarelin, reversal of electroosmosis (from the anode-to-cathode to the cathode-to-anode direction) was apparent; it appeared that the cationic peptide associated strongly with, and neutralized, the net negative charge on the skin, thereby resulting in depression and, ultimately, reversal of the convective flow. This, in turn, inhibits Nafarelin transport by the electroosmotic mechanism and explains, we believe, both the inverse dependence of flux upon concentration and the only weakly dependent behavior upon current density (where, although more current delivers more ions, more current also drives more peptide into the skin and thereby diminishes electroosmosis). Overall, then, this research emphasizes the complicated interplay between peptide structure, skin electrical properties and formulation variables which must be carefully considered in the development and optimization of an iontophoretic drug delivery device.

AB - The effects of administered concentration and applied current density on the iontophoresis of the leutinizing hormone releasing hormone (LHRH) analog, Nafarelin, have been studied in vitro. Peptide electrotransport, at fixed current density as a function of concentration, and at fixed concentration as a function of current density, has been measured across hairless mouse skin. The results indicate that Nafarelin delivery does not increase linearly with applied concentration: while there is an increase when the donor concentration is doubled from 0.5 to 1.0 mg/ml, further increments in applied peptide level result in decreased transport. At constant concentration, Nafarelin flux does increase with increasing current density (up to 0.63 mA/cm2), but the dependence is very weak. Further experiments utilizing radiolabeled mannitol as a neutral marker of electroosmosis revealed that Nafarelin electrotransport is very sensitive to the extent and direction of convective flow. With increasing amounts of applied Nafarelin, reversal of electroosmosis (from the anode-to-cathode to the cathode-to-anode direction) was apparent; it appeared that the cationic peptide associated strongly with, and neutralized, the net negative charge on the skin, thereby resulting in depression and, ultimately, reversal of the convective flow. This, in turn, inhibits Nafarelin transport by the electroosmotic mechanism and explains, we believe, both the inverse dependence of flux upon concentration and the only weakly dependent behavior upon current density (where, although more current delivers more ions, more current also drives more peptide into the skin and thereby diminishes electroosmosis). Overall, then, this research emphasizes the complicated interplay between peptide structure, skin electrical properties and formulation variables which must be carefully considered in the development and optimization of an iontophoretic drug delivery device.

KW - Electroosmosis

KW - Iontophoresis

KW - Nafarelin

KW - Peptide delivery

KW - Skin

KW - Transdermal delivery

UR - http://www.scopus.com/inward/record.url?scp=0029040885&partnerID=8YFLogxK

UR - http://dx.doi.org/10.1016/0168-3659(95)00015-Z

U2 - 10.1016/0168-3659(95)00015-Z

DO - 10.1016/0168-3659(95)00015-Z

M3 - Article

VL - 35

SP - 35

EP - 40

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

IS - 1

ER -